Approval · Notice of Compliance 2059 · 1999
INNOHEP: Notice of Compliance 2059
Issued December 17, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2059
- Date
- December 17, 1999
- Company
- Leo Laboratories Canada Ltd.
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: prevention of clotting in indwelling intravenous lines during haemodialysis and extracorporeal circulation
- Therapeutic class
- Anticoagulant/antithrombotic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| INNOHEP | Not yet assigned | — |
Medicinal ingredients
- TINZAPARIN SODIUM 10,000 UNIT per ML